Suchergebnisse - "Preiss, R"

PubPharm (141)

1

SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE (PAH-CHD) AFTER DEFECT CORRECTION: INSIGHTS FROM THE RANDOMISED CONTROLLED GRIPHON STUDY

enthalten in: The Canadian journal of cardiology | 2016

von Langleben, D. | Beghetti, M. | Channick, R. | +13

2

Cibler la voie de la prostacycline dans le traitement des HTAP associées aux connectivites : expérience de Griphon – étude contrôlée, randomisée avec le selexipag

enthalten in: Revue de médecine interne | 2016

von Hachulla, E. | Gaine, S. | Channick, R. | +12

3

S109 Targeting the prostacyclin pathway in the treatment of connective tissue disease associated pulmonary arterial hypertension (pah): insights from the randomised controlled griphon trial with selexipag

enthalten in: Thorax | 2016

von Coghlan, G. | Gaine, S. | Channick, R. | +12

4

Phase-I-Studie zur Behandlung von hilären Gallengangskarzinomen mit Bendamustin

enthalten in: Zeitschrift für Gastroenterologie | 2015

von Kreth, F. | Wiedmann, M. | Feisthammel, J. | +3

5

Recreational athletes and doping--a survey in 11 gyms in the area of Frankfurt/Main

enthalten in: MMW Fortschritte der Medizin | 2013

von Raschka, C. | Chmiel, C. | Preiss, R. | +1

6

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

enthalten in: Annals of the rheumatic diseases | 2011

von Kuemmerle-Deschner, J. | Hachulla, E. | Cartwright, R. | +15

7

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

enthalten in: Annals of the rheumatic diseases | 2011

von Kuemmerle-Deschner, J. | Hachulla, E. | Cartwright, R. | +15

8

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

enthalten in: Pediatric rheumatology | 2011

von Ruperto, N. | Brunner, H. | Horneff, G. | +16

9

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

enthalten in: Pediatric rheumatology | 2011

von Bader-Meunier, B. | Hachulla, P. | Kuemmerle-Deschner, J. | +10

10

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

enthalten in: Pediatric rheumatology | 2011

von Ruperto, N. | Brunner, H. | Horneff, G. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]